Plasma pTau217 levels and conversion to MCI in the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin ADRC

Abstract

Background: As the evidence base supporting the accuracy and reliability of plasma pTau217 assays continues to grow, attention has shifted towards establishing their diagnostic and clinical utility. The aim of the current study was to examine the association between plasma pTau217 levels and conversion to MCI in a preclinical cohort.